{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:18:25Z","timestamp":1778577505834,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2028,4,2]],"date-time":"2028-04-02T00:00:00Z","timestamp":1838246400000},"content-version":"am","delay-in-days":641,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["24K0328 6"],"award-info":[{"award-number":["24K0328 6"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009031","name":"Japan Agency for Medical Research and Development Department of Industrial Academic Collaboration","doi-asserted-by":"publisher","award":["JP25yf0126003"],"award-info":[{"award-number":["JP25yf0126003"]}],"id":[{"id":"10.13039\/501100009031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007962","name":"Jikei University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013236","name":"Public Interest Incorporated Foundation MSD Life Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apradiso.2026.112598","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:58:35Z","timestamp":1774972715000},"page":"112598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficient conjugation of chelator agents to IgG and accurate colorimetric determination of the chelator-to-IgG molar ratio"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-1856","authenticated-orcid":false,"given":"Masayuki","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi B.","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.apradiso.2026.112598_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jlcr.3897","article-title":"Preparation, quality control, and biodistribution assessment of [111 In]In-DOTA-PR81 in BALB\/c mice bearing breast tumors","volume":"64","author":"Abadi","year":"2021","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"2","key":"10.1016\/j.apradiso.2026.112598_bib2","first-page":"355","article-title":"Production and quality control of [(67)Ga]-DOTA-trastuzumab for radioimmunoscintigraphy","volume":"12","author":"Alirezapour","year":"2013","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"issue":"6","key":"10.1016\/j.apradiso.2026.112598_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/bc960058w","article-title":"Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications","volume":"7","author":"Arano","year":"1996","journal-title":"Bioconjug. Chem."},{"issue":"9","key":"10.1016\/j.apradiso.2026.112598_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications","volume":"9","author":"Caravan","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.apradiso.2026.112598_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.675122","article-title":"Radiolabeling of human serum albumin with Terbium-161 using mild conditions and evaluation of in vivo stability","volume":"8","author":"Cassells","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.apradiso.2026.112598_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cmmi.491","article-title":"Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators","volume":"7","author":"D'Huyvetter","year":"2012","journal-title":"Contrast Media Mol. Imaging"},{"issue":"3","key":"10.1016\/j.apradiso.2026.112598_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/bc100432h","article-title":"Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting","volume":"22","author":"Hoppmann","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.apradiso.2026.112598_bib8","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1021\/ic00139a018","article-title":"Kinetics of Interaction of metal ions with two tetraaza tetraacetate macrocycles","volume":"21","author":"Kasprzyk","year":"1982","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.apradiso.2026.112598_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/ic00006a021","article-title":"Thermodynamic and kinetic studies of lanthanide complexes of 1,4,7,10,13-pentaazacyclopentadecane-N,N\u2019,N\u201d,N\u201d\u2019,N\u201d\u201d-pentaacetic Acid and 1,4,7,10,13,16-hexaazacyclooctadecane- N,N\u2019,N\u201d,N\u201d\u2019,N\u201d\u201d,N\u201d\u201d\u2019-hexaacetic acid","volume":"30","author":"Kodama","year":"1991","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.apradiso.2026.112598_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0898-8838(09)00202-5","article-title":"Design and function of metal complexes as contrast agents in MRI","volume":"61","author":"Kub\u00ed\u010dek","year":"2009","journal-title":"Adv. Inorg. Chem."},{"key":"10.1016\/j.apradiso.2026.112598_bib11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/cr00081a003","article-title":"Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design","volume":"87","author":"Lauffer","year":"1987","journal-title":"Chem. Rev."},{"key":"10.1016\/j.apradiso.2026.112598_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/bc00026a001","article-title":"Labeling monoclonal antibodies with 90Yttrium- and 111Indium-DOTA chelates: a simple and efficient method","volume":"5","author":"Li","year":"1994","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.apradiso.2026.112598_bib13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2967\/jnumed.109.062224","article-title":"Micro-SPECT\/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts","volume":"50","author":"McLarty","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112598_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(84)90517-7","article-title":"Conjugation of antibodies with bifunctional chelating agents: lsothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions","volume":"142","author":"Meares","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.apradiso.2026.112598_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/ar00102a001","article-title":"Metal chelates as probes of biological systems","volume":"17","author":"Meares","year":"1984","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.apradiso.2026.112598_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bc00016a014","article-title":"Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates","volume":"3","author":"Pippin","year":"1992","journal-title":"Bioconjug. Chem."},{"issue":"9","key":"10.1016\/j.apradiso.2026.112598_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nucmedbio.2016.06.004","article-title":"A comparative evaluation of the chelators H4octapa and CHX-A\u2033-DTPA with the therapeutic radiometal (90)Y","volume":"43","author":"Price","year":"2016","journal-title":"Nucl. Med. Biol."},{"issue":"6","key":"10.1016\/j.apradiso.2026.112598_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2967\/jnumed.110.086157","article-title":"A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer","volume":"52","author":"Rossin","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.apradiso.2026.112598_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.nucmedbio.2010.06.010","article-title":"A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer","volume":"38","author":"Scollard","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2026.112598_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/ic00302a049","article-title":"Synthesis and characterization of the Gadolinium(3+) complex of DOTA-propylamide: a model DOTA-protein conjugate","volume":"28","author":"Sherry","year":"1989","journal-title":"Inorg. Chem."},{"issue":"12","key":"10.1016\/j.apradiso.2026.112598_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/ph14121251","article-title":"Humanization, radiolabeling and biodistribution studies of an IgG1-type antibody targeting uncomplexed PSA for theranostic applications","volume":"14","author":"Strand","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apradiso.2026.112598_bib22","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1111\/cas.15978","article-title":"Head-to-head comparison of three chelates reveals DOTAGA promising for 225Ac labeling of anti-FZD10 antibody OTSA101","volume":"114","author":"Sudo","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.apradiso.2026.112598_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123761","article-title":"Evaluation of efficacy of radioimmunotherapy with 90Y-labeled fully human anti-transferrin receptor monoclonal antibody in pancreatic cancer mouse models","volume":"10","author":"Sugyo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apradiso.2026.112598_bib24","first-page":"132","article-title":"Reduction of the hepatic radioactivity levels of [111In]In-DOTA-labeled antibodies via cleavage of a linkage metabolized in lysosomes","author":"Suzuki","year":"2024","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"10.1016\/j.apradiso.2026.112598_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nucmedbio.2004.08.003","article-title":"Imaging of HER2\/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments","volume":"32","author":"Tang","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2026.112598_bib26","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/cancers13143469","article-title":"A Conjugation strategy to modulate antigen binding and FcRn interaction leads to improved tumor targeting and radioimmunotherapy efficacy with an antibody targeting prostate-specific antigen","volume":"13","author":"Timmermand","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.apradiso.2026.112598_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/ic00032a034","article-title":"A Kinetic Investigation of the lanthanide DOTA chelates. stability and rates of formation and of dissociation of a macrocyclic Gadolinium(III) polyaza polycarboxylic MRI contrast agent","volume":"31","author":"Wang","year":"1992","journal-title":"Inorg. Chem."},{"issue":"4","key":"10.1016\/j.apradiso.2026.112598_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0730-725X(92)90016-S","article-title":"Dissociation of gadolinium chelates in mice: relationship to chemical characteristics","volume":"10","author":"Wedeking","year":"1992","journal-title":"Magn. Reson. Imaging"},{"issue":"14","key":"10.1016\/j.apradiso.2026.112598_bib29","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.3390\/cancers15143660","article-title":"Optimization of radiolabeling of a [90Y]Y-Anti-CD66-antibody for radioimmunotherapy before allogeneic hematopoietic cell transplantation","volume":"15","author":"Winter","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980432600182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980432600182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:48:59Z","timestamp":1778575739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980432600182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S096980432600182X"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112598","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient conjugation of chelator agents to IgG and accurate colorimetric determination of the chelator-to-IgG molar ratio","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112598"}}